Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovaXS is a medical technology company developing Telosis, a smart, needle-free drug delivery platform designed to improve the experience of patients requiring frequent self-injections. The system uses advanced pressure technology to deliver medications through the skin without a needle, coupled with a mobile app that tracks treatment progress and provides real-time data to healthcare providers. Initially focusing on the fertility market for IVF treatments and pediatric growth hormone therapy, the company aims to increase patient compliance and reduce the pain and anxiety associated with traditional injections. NovaXS's technology integrates IoT capabilities to ensure precise dosing and monitoring for chronic disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NovaXS.